福泰制药Vertex Pharmaceuticals Inc. (VRTX) 2014年10-K年度报告「NASDAQ」.pdf

1、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/13/15 for the Period Ending 12/31/14 Address50 NORTHERN AVENUEBOSTON,MA 02210Telephone6173416393CIK0000875320SymbolVRTXSIC Code2834-Pharmaceutical PreparationsIndustryBiotechnology&DrugsSectorHealthcareFiscal Year12/31http:/www.edgar- Cop

2、yright 2015,EDGAR Online,Inc.All Rights Reserved.Distribution and use of this document restricted under EDGAR Online,Inc.Terms of Use.UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 _ FORM 10-K Commission file number 000-19319 _ Vertex Pharmaceuticals Incorporated (Exact name o

3、f registrant as specified in its charter)Registrants telephone number,including area code(617)341-6100 _ Securities registered pursuant to Section 12(b)of the Exchange Act:Securities registered pursuant to Section 12(g)of the Exchange Act:None _ Indicate by check mark if the registrant is a well-kno

4、wn seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No?Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Exchange Act.Yes?No Indicate by check mark whether the registrant:(1)has filed all reports required to be file

5、d by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No?Indicate by check mark whether the registrant

6、 has submitted electronically and posted on its corporate Web site,if any,every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the registrant was required to submi